6 Drug Recalls and Pharmacy Response

What a recall means

A drug recall is a firm’s removal or correction of a product that may violate the law or present a health risk. Most recalls are initiated voluntarily by the manufacturer. The FDA oversees recall actions, assigns a health-risk classification, may request a recall, and in limited circumstances may order one.

A market withdrawal is different: it generally involves a minor issue that is not subject to FDA legal action.

Risk classification and recall scope

FDA classifications describe the risk of harm, not the number of packages affected:

• Class I: There is a reasonable probability that use or exposure could cause serious adverse health consequences or death.

• Class II: Use or exposure may cause temporary or medically reversible effects, or the probability of serious harm is remote.

• Class III: Use or exposure is unlikely to cause adverse health consequences.

Recall depth describes how far through the distribution chain the action reaches, such as to wholesalers, pharmacies, or patients. Follow the specific recall notice: affected lots, products, and required actions matter more than the class alone. A recall may appear in an FDA report as “not yet classified” while the FDA evaluates it. Do not delay appropriate action while awaiting a final classification.

Find and verify recall notices

Recall information may come from a manufacturer, wholesaler, pharmacy system, the FDA, or a state board or health department. Pharmacies can check FDA Enforcement Reports and drug recall information, but not every recall receives a public announcement. When needed, verify a notice with the manufacturer or distributor, and retain the original notice and any updates.

Confirm the product name and strength, dosage form, manufacturer, National Drug Code (NDC) when listed, lot or batch number, expiration date, and distribution dates. Compare the notice with inventory and purchasing records; do not assume every package of a product is affected.

Assess risk and contain affected stock

Act promptly, especially when a hazard may be serious. The pharmacist or designated recall lead should:

1. Read the notice for the reason, affected products and lots, health risk, recall depth, deadlines, and instructions for return, destruction, or correction.

2. Identify stock on shelves, in the dispensing area, and in automated or other storage systems. Use invoices, wholesaler records, and dispensing records to locate affected inventory and, when indicated, patients who received it.

3. Remove affected stock from sale and dispensing. Mark it “Do not use—recalled” and place it in a physically separate, access-controlled quarantine area. Maintain appropriate storage conditions. Do not return, destroy, or otherwise dispose of the stock until the notice’s instructions are followed.

4. Escalate unclear instructions, possible exposure, serious hazards, or suspected patient harm to the pharmacist in charge and the manufacturer or distributor. Follow applicable state requirements and the pharmacy’s recall procedures.

The classification helps describe risk, but the notice and clinical circumstances guide the response. A Class I notice may require urgent patient outreach, while a limited wholesale-level correction may call for inventory action only. Do not automatically advise patients to stop a prescribed medicine, because interruption may itself be harmful. For an affected patient, explain the notice, assess urgency, and promptly coordinate with the prescriber or manufacturer about replacement or next steps. The FDA advises patients to follow the recalling company’s instructions and consult a pharmacist or clinician with questions.

Communicate and document actions

Notify staff who could dispense or handle the product, and ensure affected inventory cannot be selected for dispensing. Contact patients or prescribers when the notice, risk, distribution level, or pharmacy policy calls for it. Follow the manufacturer’s instructions and use an appropriate communication method; explain how to identify the affected product and what action to take. For urgent risks, use timely direct outreach rather than relying only on a general posting. Record unsuccessful contact attempts and escalate them when warranted.

Maintain a recall file documenting:

• The notice, date received, source, and any revisions.

• Product identifiers and affected lots, along with inventory and dispensing-record checks.

• Quantities located, quarantined, returned, corrected, or destroyed, with dates and evidence of disposition.

• Staff instructions; patient and prescriber contacts; contact attempts; and clinical referrals.

• Questions raised, responses from the manufacturer or authorities, and the person responsible for each action.

Follow up and close the recall

Reconcile the amount of recalled stock found with purchasing, dispensing, and return or disposal records. Confirm that the quarantine remains secure, required notifications and responses are complete, and no affected product remains available for dispensing. Follow up on manufacturer requests for confirmation or effectiveness checks, and retain records under applicable law and pharmacy policy.

If a patient may have experienced an adverse event, arrange appropriate clinical follow-up and consider reporting it to FDA MedWatch. Close the action only after required steps are complete and documented. The FDA evaluates whether recall notifications and removal efforts are effective and may take further action if a recall is inadequate.